Arcus, Gilead report Phase 3 TIGIT failure in upper GI cancers
Arcus, Gilead report Phase 3 TIGIT failure in upper GI cancers
Arcus, Gilead report Phase 3 TIGIT failure in upper GI cancers
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.